Terms: = Liver cancer AND LIFR, SJS2, 3977, ENSG00000113594, SWS, STWS, CD118 AND Treatment
7 results:
1. A targetable lifr-NF-κB-LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis.
Yao F; Deng Y; Zhao Y; Mei Y; Zhang Y; Liu X; Martinez C; Su X; Rosato RR; Teng H; Hang Q; Yap S; Chen D; Wang Y; Chen MM; Zhang M; Liang H; Xie D; Chen X; Zhu H; Chang JC; You MJ; Sun Y; Gan B; Ma L
Nat Commun; 2021 Dec; 12(1):7333. PubMed ID: 34921145
[TBL] [Abstract] [Full Text] [Related]
2. M
Chen JQ; Tao YP; Hong YG; Li HF; Huang ZP; Xu XF; Zheng H; Hu LK
Cell Cycle; 2021 Dec; 20(23):2507-2518. PubMed ID: 34658294
[TBL] [Abstract] [Full Text] [Related]
3. Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients.
Owusu Sekyere S; Port K; Deterding K; Cornberg M; Wedemeyer H
United European Gastroenterol J; 2021 May; 9(4):486-496. PubMed ID: 33349201
[TBL] [Abstract] [Full Text] [Related]
4. A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.
Chan SL; Yeo W; Mo F; Chan AWH; Koh J; Li L; Hui EP; Chong CCN; Lai PBS; Mok TSK; Yu SCH
Cancer; 2017 Oct; 123(20):3977-3985. PubMed ID: 28640364
[TBL] [Abstract] [Full Text] [Related]
5. Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
Karunanithy N; Gordon F; Hodolic M; Al-Nahhas A; Wasan HS; Habib N; Tait NP
Cardiovasc Intervent Radiol; 2011 Apr; 34(2):287-94. PubMed ID: 20700593
[TBL] [Abstract] [Full Text] [Related]
6. Leukemia inhibitory factor receptor (lifr) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.
Okamura Y; Nomoto S; Kanda M; Li Q; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
Cancer Lett; 2010 Mar; 289(2):170-7. PubMed ID: 19733004
[TBL] [Abstract] [Full Text] [Related]
7. Phase II study of prolonged oral etoposide in combination with intravenous cisplatin in advanced non-small cell lung cancer.
Miller AA; Niell HB; Griffin JP
Lung Cancer; 1995 Mar; 12(1-2):59-65. PubMed ID: 7600031
[TBL] [Abstract] [Full Text] [Related]
